Kawasaki Disease Program Overview

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Kawasaki Disease Program

The Kawasaki Disease Program at Boston Children's Hospital - part of the #1 ranked Heart Center - provides coordinated care for patients with Kawasaki Disease, both during the acute phase and in long-term follow-up. Kawasaki disease causes inflammation of many tissues of the body, including the hands, feet, whites of the eyes, mouth, lips and throat. The most concerning aspect of Kawasaki disease is its potential effect on the heart and blood vessels. Heart-related complications can be temporary or may affect children long-term. Please contact us today for a consultation or second opinion.

About Kawasaki Disease

Kawasaki disease is a rare condition that can cause inflammation in many of the tissues and blood vessels of a child’s body, including her mouth, skin, eyes and lymph nodes. The cause is unknown, but if the symptoms are recognized early, kids with Kawasaki disease can fully recover within a few days. If left untreated, it can lead to serious complications that can affect the heart.

Learn more about Kawasaki disease and how we care for children with Kawasaki disease.

Our expertise

Experienced staff

Jane Newburger of Boston Children's HospitalPhysicians and nurses at Boston Children's Hospital treat more than 50 new patients each year for definite or suspected Kawasaki disease, and follow more than 1,400 children and young adults in the long-term Kawasaki Disease Program. This multidisciplinary program is staffed by cardiologists, rheumatologists and a pediatric nurse practitioner.

 

 

International resource

The Kawasaki Disease Program at Boston Children's Hospital serves as a national and international resource for parents and physicians. A member of the Kawasaki Disease Program is on call 24 hours a day, seven days a week, to provide consultation.

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO
Close